Allianz Asset Management GmbH Cuts Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Allianz Asset Management GmbH decreased its holdings in Pediatrix Medical Group, Inc. (NYSE:MDFree Report) by 16.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 532,914 shares of the company’s stock after selling 108,722 shares during the quarter. Allianz Asset Management GmbH owned 0.63% of Pediatrix Medical Group worth $4,956,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in MD. Boston Partners purchased a new stake in Pediatrix Medical Group during the 4th quarter worth about $12,452,000. Pacer Advisors Inc. increased its stake in shares of Pediatrix Medical Group by 126.9% during the fourth quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after buying an additional 1,809,828 shares during the period. Connable Office Inc. acquired a new stake in Pediatrix Medical Group in the fourth quarter valued at approximately $217,000. Charles Schwab Investment Management Inc. lifted its stake in Pediatrix Medical Group by 10.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock worth $15,197,000 after acquiring an additional 148,600 shares during the last quarter. Finally, Smith Graham & Co. Investment Advisors LP grew its holdings in Pediatrix Medical Group by 51.5% during the 4th quarter. Smith Graham & Co. Investment Advisors LP now owns 534,621 shares of the company’s stock worth $4,972,000 after acquiring an additional 181,662 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on MD. Jefferies Financial Group decreased their price objective on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, March 6th. Mizuho decreased their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st. Truist Financial reiterated a “hold” rating and issued a $10.00 price objective on shares of Pediatrix Medical Group in a report on Wednesday, May 15th. Finally, TheStreet cut Pediatrix Medical Group from a “c” rating to a “d” rating in a research note on Friday, February 23rd. Five analysts have rated the stock with a hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $9.38.

Check Out Our Latest Stock Analysis on MD

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $7.15 on Thursday. The stock’s 50-day moving average is $8.66 and its two-hundred day moving average is $9.02. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1 year low of $7.02 and a 1 year high of $15.02.

Pediatrix Medical Group (NYSE:MDGet Free Report) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.02. Pediatrix Medical Group had a positive return on equity of 10.31% and a negative net margin of 3.53%. The firm had revenue of $495.10 million for the quarter, compared to the consensus estimate of $496.25 million. As a group, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.13 earnings per share for the current year.

About Pediatrix Medical Group

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Recommended Stories

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MDFree Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.